Overview
Envista Holdings Corporation, based in the United States, operates primarily in the dental products and technologies sector. The company provides a comprehensive range of products and solutions that cater to dental professionals, including dental implants, orthodontics, and digital imaging technologies. A significant aspect of Envista's operations includes its focus on digital innovations with DEXIS imaging solutions and the Nobel Biocare implant systems, aiming to enhance diagnostics and treatment planning in dentistry. Envista Holdings frequently engages in strategic acquisitions to broaden its technological capabilities and market reach, fortifying its position as a leading player in the dental industry globally. The corporation's strategic development is centered on integrating advanced technologies with professional dental care practices to drive growth and improve patient outcomes.
Basic Stats
The share price of Envista Holdings Corporation as of September 4, 2025 is $20.78 / share. This is a decrease of -2.21% from the prior week. The market cap (or net worth) of Envista Holdings Corporation as of September 4, 2025 is $3,466.10 MM.
The Factor Analysis chart (below right) shows a view of Envista Holdings Corporation from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 3,466.10 MM |
| EV | 3,916.80 MM |
| Shares Out. | 166.80 MM |
| Earnings Date | |
| EPS (TTM) | 0.32 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.26 |
| Short Shares Avail. | 2.10 MM |
| Short Interest | 10.31 MM |
| Short Float | 6.23 % |
| Days to Cover | 8.03 days |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | 20.67 % |
| Volatility (1 yr) | 0.42 |
| Beta | 1.10 |
| Sharpe Ratio (1 yr) | 0.39 |
| Sortino Ratio (1 yr) | 0.72 |
| PE Ratio | 64.43 |
| Price/Book | 1.10 |
| Price/TBV | 33.55 |
| Book/Market | 0.91 |
| EBIT/EV | 0.03 |
| EBIT(3yr avg)/EV | -0.08 |
| ROA | 0.01 |
| ROE | 0.02 |
| ROIC | 0.01 |
| CROIC | 0.02 |
| OCROIC | 0.06 |
| Implied Volatility | 37.38 % |
| Put/Call OI Ratio | 0.21 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Envista Holdings Corporation is $21.98. The forecasts range from a low of $17.17 to a high of $26.25. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Envista Holdings Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-02-06 | Piper Sandler | Overweight | Maintains | |
| 2022-11-04 | Piper Sandler | Overweight | Maintains | |
| 2022-10-13 | Morgan Stanley | Overweight | Maintains | |
| 2022-08-29 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2022-08-04 | Piper Sandler | Neutral | Maintains | |
| 2022-08-04 | Morgan Stanley | Overweight | Maintains | |
| 2022-07-21 | Goldman Sachs | Buy | Maintains | |
| 2022-07-20 | Morgan Stanley | Overweight | Maintains | |
| 2022-06-17 | Stifel | Buy | Maintains | |
| 2022-06-14 | Baird | Outperform | Neutral | Downgrade |
| 2022-05-05 | Piper Sandler | Neutral | Maintains | |
| 2022-04-04 | Morgan Stanley | Overweight | Maintains | |
| 2022-02-10 | Morgan Stanley | Overweight | Maintains | |
| 2022-01-31 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2022-01-07 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-10-26 | B of A Securities | Neutral | Buy | Upgrade |
| 2021-05-07 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-05-06 | Credit Suisse | Outperform | Maintains | |
| 2021-03-25 | Credit Suisse | Outperform | Maintains | |
| 2021-02-12 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-02-11 | Credit Suisse | Outperform | Maintains | |
| 2021-01-08 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2020-12-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-11-25 | B of A Securities | Neutral | Maintains | |
| 2020-11-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-10-30 | Credit Suisse | Neutral | Maintains | |
| 2020-09-15 | B of A Securities | Neutral | Maintains | |
| 2020-08-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-07-20 | B of A Securities | Neutral | Maintains | |
| 2020-06-16 | Piper Sandler | Neutral | Initiate | |
| 2020-06-01 | JP Morgan | Overweight | Maintains | |
| 2020-05-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-05-13 | Credit Suisse | Neutral | Maintains | |
| 2020-05-13 | Baird | Outperform | Maintains | |
| 2020-05-13 | B of A Securities | Neutral | Reiterate | |
| 2020-03-17 | JP Morgan | Overweight | Maintains | |
| 2019-10-14 | William Blair | Outperform | Initiate | |
| 2019-10-14 | Stifel Nicolaus | Buy | Initiate | |
| 2019-10-14 | Morgan Stanley | Equal-Weight | Initiate | |
| 2019-10-14 | JP Morgan | Overweight | Initiate | |
| 2019-10-14 | Jefferies | Buy | Initiate | |
| 2019-10-14 | Goldman Sachs | Buy | Initiate | |
| 2019-10-14 | Credit Suisse | Neutral | Initiate | |
| 2019-10-14 | Bank of America | Neutral | Initiate | |
| 2019-10-14 | Baird | Outperform | Initiate | |
| 2023-02-09 | Baird | Neutral | Maintains | |
| 2023-05-04 | Morgan Stanley | Overweight | Maintains | |
| 2023-10-26 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-10-20 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-11-03 | Goldman Sachs | Buy | Buy | Maintains |
| 2023-11-02 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-11-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-11-16 | Needham | Hold | Initiate | |
| 2023-11-02 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2023-07-11 | B of A Securities | Buy | Buy | Maintains |
| 2023-11-01 | Stifel | Buy | Buy | Maintains |
| 2024-04-26 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2024-02-26 | Leerink Partners | Underperform | Initiate | |
| 2024-02-09 | Jefferies | Buy | Hold | Downgrade |
| 2024-05-03 | Goldman Sachs | Sell | Sell | Maintains |
| 2024-05-02 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-05-02 | Baird | Neutral | Neutral | Maintains |
| 2024-05-02 | Needham | Hold | Reiterate | |
| 2024-06-03 | Needham | Hold | Reiterate | |
| 2024-02-08 | William Blair | Outperform | Market Perform | Downgrade |
| 2024-01-05 | UBS | Neutral | Initiate | |
| 2024-06-25 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-07-16 | Needham | Hold | Reiterate | |
| 2024-08-08 | B of A Securities | Buy | Buy | Maintains |
| 2025-01-23 | Jefferies | Hold | Hold | Maintains |
| 2024-07-30 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-08-01 | Stifel | Buy | Buy | Maintains |
| 2025-08-01 | Mizuho | Underperform | Underperform | Maintains |
| 2025-08-01 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-01 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-01 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-04-29 | B of A Securities | Buy | Buy | Maintains |
| 2024-10-31 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-07-22 | Baird | Neutral | Neutral | Maintains |
| 2024-07-30 | Stifel | Buy | Buy | Maintains |
| 2024-10-08 | Wells Fargo | Equal-Weight | Initiate | |
| 2024-12-04 | Mizuho | Underperform | Initiate | |
| 2024-10-31 | Needham | Hold | Reiterate | |
| 2024-10-31 | Baird | Neutral | Neutral | Maintains |
| 2024-10-31 | Leerink Partners | Underperform | Market Perform | Upgrade |
| 2024-08-08 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-08-08 | JP Morgan | Overweight | Neutral | Downgrade |
| 2024-08-08 | Needham | Hold | Reiterate | |
| 2024-10-23 | Stifel | Buy | Buy | Maintains |
| 2025-02-06 | Needham | Hold | Hold | Reiterate |
| 2025-04-30 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-02-25 | Needham | Hold | Hold | Reiterate |
| 2025-03-06 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-03-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-03-06 | Needham | Hold | Hold | Reiterate |
| 2025-02-03 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-02-06 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-09-23 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-07-09 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-03-10 | UBS | Neutral | Neutral | Maintains |
| 2025-05-05 | UBS | Neutral | Neutral | Maintains |
| 2025-05-27 | Baird | Neutral | Outperform | Upgrade |
| 2025-07-29 | UBS | Neutral | Neutral | Maintains |
